Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Global pharma major Pfizer and BioNTech SE on Monday said trial results of Covid-19 vaccine showed that it is safe and produced robust neutralising antibody response in children aged five to 11......

In talks with India over 'expedited approval' of Covid vaccine: Pfizer

Pfizer is in discussions with the Indian government for an expedited approval pathway to make Pfizer-BioNTech vaccine available in the country, its chief Albert Bourla said on Monday, while stating......

Third dose of COVID vaccine 'likely' needed within 1 year: Pfizer boss

Pfizer's CEO Albert Bourla has said that COVID-19 vaccine recipients will "likely" need a third dose between six to 12 months after they're fully vaccinated and suggested vaccinations for......

Production of 1 bn vax doses in India on track: Biden

The Quad partnership is on track to produce at least a billion vaccine doses in India by 2022, US President Joe Biden said on Wednesday, asserting that nothing is more urgent than working together......

Pfizer, BioNTech to supply vaccines at Tokyo Olympics

IMAGE: 'This year's Olympic and Paralympic Games are an historic moment representing the global community and how we stand together. We are honoured to be able to contribute the vaccine to support......